i3 Health’s mission is to enhance the proficiency of the interprofessional healthcare team by providing evidence-based, fair-balanced CME/NCPD/CPE-approved activities that address identified professional practice gaps and unmet educational needs.
…
continue reading
Um podcast semanal sobre o mercado de impressão 3D na indústria 4.0 e na educação STEM/STEAM.
…
continue reading
Pembicaraan yang tidak begitu jelas namun terima kasih sudah mendengarkan ✨
…
continue reading
I am an autistic mentally and physically disabled individual. All I have is a brain of ideas and the hope of creating change and making my mark on the world while I'm here. Send me a message or an email feel free I love feedback and requests. Facebook: https://www.facebook.com/boyxtragic/ Instagram: @RyanXRockstar Twitter: @BlackAsIce Support this podcast: https://podcasters.spotify.com/pod/show/baby2020/support
…
continue reading

1
Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies - Module 1
30:14
30:14
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
30:14Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies - Module 1 by i3 HealthKirjoittanut i3 Health
…
continue reading

1
Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies - Module 2
27:41
27:41
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
27:41Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies - Module 2 by i3 HealthKirjoittanut i3 Health
…
continue reading

1
Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 1
41:12
41:12
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
41:12Schizophrenia is a debilitating mental illness that significantly impacts thought processes, perceptions, emotions, and social interactions. In Module 1 of this podcast, expert Dr. Christoph U. Correll explores the limitations of current dopamine-blocking therapies and discusses ongoing efforts to optimize treatment approaches. Stay informed on the…
…
continue reading

1
Additional Advances in Relapsed/Refractory Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP
48:31
48:31
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
48:31The fight against relapsed/refractory multiple myeloma is evolving rapidly, with groundbreaking research and clinical trials paving the way for innovative treatments. But as new therapies emerge, addressing healthcare disparities and improving access to these life-changing advancements has never been more critical.In this episode, Dr. Rahul Banerje…
…
continue reading

1
Additional Advances in Plaque Psoriasis Clinical Trials and Research With Steven Feldman, MD, PhD
9:58
Plaque psoriasis is more than just a skin condition—it’s a chronic, immune-mediated disorder that can deeply affect a person’s quality of life. That’s why it’s essential for healthcare professionals to develop effective patient education strategies that address safety concerns, improve communication, and encourage therapy adherence.In this episode,…
…
continue reading

1
Additional Advances in ALS Clinical Trials and Research With Sabrina Paganoni, MD, PhD + Module 2
22:30
22:30
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
22:30In this episode, Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts General Hospital, discusses the latest advancements in early diagnosis and treatment of amyotrophic lateral sclerosis (ALS), a progressive neurological disorder that leads to motor neuron degeneration and muscle atrophy. Following the…
…
continue reading

1
Additional Advances in ALS Clinical Trials and Research with Sabrina Paganoni, MD, PhD + Module 1 Activity
29:41
29:41
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
29:41In this episode, we explore amyotrophic lateral sclerosis (ALS) with Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts General Hospital, who shares insights on early detection and emerging treatments for this progressive neurological disorder. Following the interview, listeners can participate in an …
…
continue reading

1
Additional Advances in Stem Cell Mobilization Research and Clinical Trials in Multiple Myeloma With Hamza Hashmi, MD
8:23
March marks Multiple Myeloma Awareness Month, a crucial time to highlight advances in the treatment of this complex blood cancer. Multiple myeloma is the leading indication of autologous hematopoietic stem cell transplantation (ASCT) in hematologic malignancies, with high-dose therapy followed by ASCT representing a potentially curative treatment m…
…
continue reading

1
Additional Advances in Renal Cell Carcinoma Research and Clinical Trials With Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC
10:31
10:31
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
10:31As we recognize Kidney Cancer Awareness Month this March, advancements in renal cell carcinoma (RCC) treatment continue to evolve. Recently, Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC, a Nurse Practitioner and expert in genitourinary oncology, chaired the i3 Health’s NCPD activity titled Toxicity Management and Symptom Control in Advanced RCC: Playb…
…
continue reading

1
Softwares e materiais para I3D de resinas, com Feliipe Wolf
1:04:26
1:04:26
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:04:26Em mais um encontro com o super Felipe Wolf vamos nos aprofundar em impressoras 3D de resina, com uma cobertura completa dos softwares Tango, da polêmica VoxelDance e o software Utools, um suporte obrigatório a todos que possuam impressoras 3D de resina, mas que infelizmente, não é compatível em suas versões mais recentes com as impressoras da Crea…
…
continue reading

1
Additional Advances in MCED Technologies: MCED Testing and Shared Decision Making + Module 3 Activity
28:55
28:55
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
28:55Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health’s three-part microlearning series, Optimizing Cancer Screening with M…
…
continue reading

1
Additional Advances in MCED Technologies: Cancer Survivorship and Emerging Trials + Module 2 Activity
24:24
24:24
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
24:24Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health’s three-part microlearning series, Optimizing Cancer Screening with M…
…
continue reading

1
Additional Advances in MCED Technologies: The Impact of MCED Testing + Module 1 Activity
25:48
25:48
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
25:48Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health’s three-part microlearning series, Optimizing Cancer Screening with M…
…
continue reading

1
Será 2025 o ano da impressão de resina?
1:18:47
1:18:47
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:18:47Neste episódio de estreia no ano de 2025 discutimos com nosso super convidado, Felipe Wolf, qual será o futuro das impressoras 3D de resina. Links do episódio: VoxelDance | Additive Manufacturing Software | 3D Printing Software ProviderFormnext 2024 Highlights: Financial Stress, Industry Shifts, and Emerging Innovators « Fabbaloo nTop confirms Voxe…
…
continue reading

1
Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 4
18:20
18:20
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
18:20Schizophrenia is a highly complex and multifactorial mental illness, with symptoms, presentations, and outcomes varying widely among individuals. Genetic, environmental, and personal factors all play a role in disease progression, making individualized treatment essential for optimal outcomes.In Module 4 of this podcast, expert Dr. Christoph U. Cor…
…
continue reading

1
Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 3
19:10
19:10
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
19:10Cognitive impairment is a core feature of schizophrenia, significantly contributing to functional disability and long-term challenges. Patients often experience poor attention, disorientation, stereotyped thinking, and difficulty with abstract thought, all of which hinder daily functioning and independence.In Module 3 of this podcast, expert Dr. Ch…
…
continue reading

1
Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 2
21:04
21:04
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
21:04Schizophrenia affects over 24 million people worldwide, yet treatment adherence remains a significant challenge due to side effects and complex dosing schedules of oral antipsychotics. Long-acting injectables (LAIs) offer a promising alternative, providing less frequent dosing, improved adherence, and more stable blood concentrations, which may lea…
…
continue reading

1
Additional Advances in Hemophilia Research and Clinical Trials With Guy Young, MD
54:33
54:33
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
54:33Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology-Oncology, and Professor of Pediatrics at Keck School of Medicine at the University of Southern California (USC), is currently serving as co-chair of i3 Health’s CME/NCPD activity, Practice-Changing Advances in the Management of Hemophilia. With new d…
…
continue reading

1
Implementing AI Into Healthcare Education: The Ethical and Legal Landscape
22:20
22:20
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
22:20Implementing AI Into Healthcare Education: The Ethical and Legal Landscape by i3 HealthKirjoittanut i3 Health
…
continue reading

1
Best Practices and Emerging Evidence in the Treatment of Atopic Dermatitis in Children and Adolescents
35:40
35:40
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
35:40Tune in to the latest podcast episode, Best Practices and Emerging Evidence in the Treatment of Atopic Dermatitis in Children and Adolescents, where experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold discuss cutting-edge advancements in pediatric AD care. Learn about new therapies, including nonsteroidal topicals, JAK inhibitors, monoclonal antib…
…
continue reading

1
What’s New With HER2: Charting New Paths in NSCLC Care Module 1 Podcast: HER2 in NSCLC: Actionable Insights and Testing Recommendations
15:24
15:24
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
15:24Stay ahead in NSCLC management with this accredited podcast! HER2 alterations, including gene mutations and protein overexpression, are key therapeutic targets, but their complexity can challenge treatment decisions.In Module 1 of this podcast, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cance…
…
continue reading

1
What’s New With HER2: Charting New Paths in NSCLC Care Module 2 Podcast
18:34
18:34
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
18:34Stay ahead in NSCLC management with our accredited podccast! HER2 alterations, including gene amplifications, mutations, and protein overexpression, are critical therapeutic targets, but their heterogeneity can complicate treatment strategies.In Module 2, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-F…
…
continue reading

1
Diagnosis and Management of Dedifferentiated Liposarcoma: A Multidisciplinary Task Force Podcast
28:57
28:57
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
28:57Gain valuable insights into the complexities of diagnosing and managing dedifferentiated liposarcoma (DDLPS) and earn free CME credit with our latest podcast. This episode features expert guidance from Dr. Richard F. Riedel of Duke University and Dr. Candace L. Haddox of Dana-Farber Cancer Institute. Delve into the latest on identifying MDM2 and CD…
…
continue reading

1
National Alzheimer Disease Awareness Month: Advances in Diagnosis and Research With Nathaniel Chin, MD
14:25
14:25
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
14:25Click the links below for the full activity! Online Accredited CME/NCPD Activity: https://i3health.com/course-information/Alzheimer-disease Live In-Person or Virtual Meeting: https://i3health.com/live/Exploring%20Advances%20in%20the%20Early%20Diagnosis%20and%20Treatment%20of%20Alzheimer%20DiseaseNovember is National Alzheimer Disease Awareness Mont…
…
continue reading
i3 Health is pleased to invite you to Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, a free, live webinar held on November 7 at 10:00 am Eastern and November 19 at 11:30 am Eastern. This interview features an exclusive preview from the two webinar co-chairs, Dr. Filipa Lynce, Director of the Inflammatory Breast …
…
continue reading
Dr. Deborah Wong, Director of the Medical Oncology Program and Clinical Trials Program for Head and Neck Squamous Cell Cancers (HNSCC) and an Associate Clinical Professor of Medicine at the University of California Los Angeles (UCLA) is currently serving as co-chair of i3 Health’s accredited CME/NCPD activity, Recurrent and Metastatic HNSCC, Harnes…
…
continue reading

1
Navigating Patients Through the CKD Journey by Enhancing Value-Based Care - CPE & Interview
1:55:41
1:55:41
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:55:41Jeff Sperry, PharmD, BCPS, a Clinical Pharmacist at UCHealth Memorial Hospital, sat down with the Pharmacy Podcast Network to discuss additional advances in chronic kidney disease since recording the i3Health CPE-accredited activity, Slowing Progression of Chronic Kidney Disease Through Value-Based Care. Following the interview, continue listening …
…
continue reading

1
Additional Advances in Alzheimer Disease Research and Clinical Trials With Nathaniel Chin, MD
14:18
14:18
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
14:18Dr. Nathaniel Chin, Associate Professor of Medicine in the Division of Geriatrics and Gerontology at the University of Wisconsin-Madison, is currently serving as chair of i3 Health’s accredited CME/NCPD activity, Exploring Advances in the Early Diagnosis and Treatment of Alzheimer Disease. With new developments in the field occurring over recent mo…
…
continue reading

1
Multicancer Early Detection Technologies: Module 3 - Implementing MCED Testing in Clinical Practice
23:43
23:43
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
23:43Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application.In Module 3 of our CME podcast, Dr. Charles Vega, Clinical Professor at the University of California, Irvine, will review the latest clinical trial data on MCED tests for gynecologi…
…
continue reading

1
Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory MM
33:18
33:18
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:18Listen now to this CME-accredited podcast, part of the Multiple Myeloma Task Force series, where we will explore strategies for mitigating disease burden and addressing health care disparities in patients with relapsed/refractory multiple myeloma. This session brings together expert insights from Task Force Co-Chairs, Dr. Sikander Ailawadhi, Profes…
…
continue reading

1
Multicancer Early Detection Technologies: Module 2 - Clinical Evidence for MCED Testing
20:13
20:13
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
20:13Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application.Join Dr. Charles Vega in Module 2 of our CME podcast as he delves into the cutting-edge world of multicancer early detection (MCED) tests. With nearly 2 million new cancer cases exp…
…
continue reading

1
Multicancer Early Detection Technologies: Module 1 - Science Behind Cancer Screening
20:16
20:16
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
20:16Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. Listen now to Module 1 and join Dr. Charles Vega, a distinguished Clinical Professor from UC Irvine, as he explores the cutting-edge realm of multicancer early detection (MCED). Dr…
…
continue reading

1
Additional Advances in Rett Syndrome Research and Clinical Trials With Timothy John Feyma, MD
5:00
Dr. Timothy John Feyma, Pediatric Neurologist at Gillette Children’s Hospital, is currently serving as chair of i3 Health’s CME/NCPD activity, Exploring Novel Treatments for Rett Syndrome. With new developments in the field occurring over recent months, Dr. Feyma sat down with us again to share new updates in treatment and management of Rett syndro…
…
continue reading

1
Practice-Changing Advances in the Management of Hemophilia
42:37
42:37
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
42:37In this podcast, hear expert perspectives on practice-changing advances in the treatment and personalized management of patients with hemophilia from Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology/Oncology, and Professor of Pediatrics at Keck School of Medicine of USC; and Dr. Jennifer Davila, Co…
…
continue reading
In this video, Dr. Jamie E. Chaft, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Leveraging the Growing Arsenal of Therapies for Early-Stage Non–Small Cell Lung Cancer (NSCLC), chaired by Dr. Helena Yu. Dr. Chaft shares insights …
…
continue reading
In this video, Dr. Catherine M. Broome, Professor of Medicine at Georgetown University Medical Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Putting the Freeze on Cold Agglutinin Disease (CAD). Dr. Broome shares insights into resources she recommends for patients with CAD, the role of thrombop…
…
continue reading

1
Getting Ahead of the ALS Curve: Module 2 – Disease-Modifying Therapies for ALS: Weighing the Options
16:51
16:51
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
16:51In Module 2 of this microlearning series and podcast, Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts Hospital and Healey & AMG Center for ALS, and Associate Professor of Physical Medicine and Rehabilitation (PM&R) at Spaulding Rehabilitation Hospital of Harvard Medical School, will share strategie…
…
continue reading

1
Getting Ahead of the ALS Curve: Module 1 – Enabling Earlier Detection of ALS
24:10
24:10
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
24:10In Module 1 of this microlearning series and podcast, Dr. Sabrina Paganoni, Co-Director of the Neurological Clinical Research Institute at Massachusetts Hospital and Healey & AMG Center for ALS, and Associate Professor of Physical Medicine and Rehabilitation (PM&R) at Spaulding Rehabilitation Hospital of Harvard Medical School, will share strategie…
…
continue reading

1
Additional Advances in Triple-Negative Breast Cancer Research and Trials: Sara M. Tolaney, MD, MPH
7:22
Last year, Dr. Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, served as co-chair of i3 Health’s webinar and online activity, Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer (TNBC). With numerous advances in TNBC research occurring since then, Dr. Tolaney sat down…
…
continue reading

1
Additional Advances in Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP
5:54
Dr. Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, Fred Hutchinson Cancer Center, is currently serving as chair of i3 Health’s online activity and fellows meeting series, Leveraging BCMA-Directed Therapies for Improved Patient Outcomes in Relapsed/Refractory Multiple Myeloma. Since recording…
…
continue reading

1
Acid Sphingomyelinase Deficiency: Answers To Frequently Asked Questions With Neal Weinreb, MD
11:15
11:15
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
11:15In this video, Dr. Neal Weinreb, Voluntary Associate Professor for Human Genetics at the University of Miami Miller School of Medicine, answers questions asked by the audience during his CME/NCPD–approved activity with i3 Health, Exploring Treatment Advances for Acid Sphingomyelinase Deficiency (ASMD) in Adults. Dr. Weinreb shares insights into scr…
…
continue reading

1
Recurrent/Metastatic HNSCC: Answers To Frequently Asked Questions With Assuntina G. Sacco, MD
11:15
11:15
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
11:15In this video, Dr. Assuntina G. Sacco, Associate Professor of Internal Medicine, Co-Director of the Hanna and Mark Gleiberman Head and Neck Cancer Center, and Disease Team Leader–Head and Neck at UC San Diego Moores Cancer Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Recurrent/Metastatic Head…
…
continue reading

1
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD
10:39
10:39
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
10:39Last year, Brian Rubin, MD, PhD, Chair of Pathology and Laboratory Medicine and the Chief of Diagnostics at the Cleveland Clinic, served as co-chair for i3 Health's continuing medical education CME NCPD #virtualtumorboard: Multidisciplinary Management of Advanced Soft Tissue Sarcoma. In this interview, Dr. Rubin sat down with Oncology Data Advisor …
…
continue reading

1
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD
8:11
Dr. Christopher Lieu, Associate Director of Clinical Research at the University of Colorado Cancer Center and Vice Chair of the National Comprehensive Cancer Network (NCCN), is currently serving as chair of i3 Health's online activity, live webinar, and meeting series, Hitting the Target in HER2-Positive Metastatic Colorectal Cancer. With numerous …
…
continue reading
Dr. Spero Cataland, Professor of Internal Medicine and the Benign Hematology Section Head at The Ohio State University, Wexner Medical Center, is currently serving as chair of i3 Health's free CME/NCPD activity and Hematology Fellows Lecture Series, Current Standards and New Directions in Treatment of Acquired Thrombotic Thrombocytopenic Purpura (a…
…
continue reading

1
Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD
7:18
Last year, Jaffer Ajani, MD, Professor in the Department of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, served as co-chair of i3 Health's Virtual Tumor Board, Building Comprehensive Care Plans in Esophagogastric Cancers, along with Lei Zhao, MD, PhD, Assistant Professor of Pathology at Brigham and Women's Hospital, and Kell…
…
continue reading

1
Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD
16:13
16:13
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
16:13At the recent American Society of Hematology (ASH) Annual Meeting, numerous updates were presented with the potential to impact practice in relapsed/refractory multiple myeloma. While at the meeting, Urvi Shah, MD, Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center, shares some of most significant highlights of the…
…
continue reading
Recently, Tanya Dorff, MD, Division Chief of the Genitourinary Disease Program at City of Hope, served as faculty for i3 Health's CME/NCPD-approved activity, Evolving Treatment Concepts and New Data in Advanced Prostate Cancer. Since recording, a plethora of new data and treatment options have been made available for prostate cancer, as well as add…
…
continue reading

1
Additional Advances in SCLC Radiotherapy With Henry Park, MD, MPH + Free CME/NCPD/CPE Podcast
52:30
52:30
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
52:30Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health’s CME/NCPD/CPE–approved activity, Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer (SCLC). This month, numerous updates in the use of radiotherapy for SCLC were presented…
…
continue reading

1
Daramao - 3D à serviço da saúde
1:01:15
1:01:15
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:01:15Pois é, pois é, entrevista dessa semana... sou eu! A Lauriane BEL da Associação Dar a mão me entrevistou, como parte do programa de lives deles para trazer informações e divulgar as ações da associação à respeito da Agenesia de membro, destacando a questão da petição online! Confira tudo nos links abaixo: Associação dar à mão http://instagram.com/d…
…
continue reading